miRecule, Inc.

miRecule is a biotechnology company developing microRNA-based therapeutics to treat cancer. We utilize a genomics based drug discovery platform to identify microRNA (miRs) targets for drug development, and subsequently create chemically modified “mimics” of these miRs with improved pharmacology and efficacy.